| 000 | 00000cam 2200000zi 4500 |
| 001 | 9.954694 |
| 003 | CaOODSP |
| 005 | 20260121084723 |
| 006 | m o d f |
| 007 | cr cn||||||||| |
| 008 | 250902t20252025onc ob f000 0 eng d |
| 020 | |a9780660787336 |
| 040 | |aCaOODSP|beng|erda|cCaOODSP |
| 043 | |an-cn--- |
| 086 | 1 |aH134-45/2025E-PDF |
| 245 | 00|aCompliance promotion : |bcomplaint investigations, adverse reaction reporting, and record keeping under the cannabis regulations. |
| 264 | 1|a[Ottawa] : |bHealth Canada = Santé Canada, |c[2025] |
| 264 | 4|c©2025 |
| 300 | |a1 online resource (6 pages) |
| 336 | |atext|btxt|2rdacontent |
| 337 | |acomputer|bc|2rdamedia |
| 338 | |aonline resource|bcr|2rdacarrier |
| 500 | |aCaption title. |
| 500 | |aIssued also in French under title: Promotion de la conformité : enquêtes sur les plaintes, déclaration des effets indésirables et tenue de dossiers conformément au règlement sur le cannabis. |
| 504 | |aIncludes bibliographical references (page 5). |
| 520 | |a"At Health Canada, we are committed to supporting cannabis licence holders (LHs) in achieving high standards of regulatory compliance. Following recent inspections of LHs, Health Canada would like to bring to your attention certain requirements under the Cannabis Regulations (CR) related to adverse reactions, particularly in the area of complaint investigations and adverse reaction reporting"--Page [1]. |
| 650 | 0|aMarijuana industry|xLicenses|zCanada. |
| 650 | 0|aCannabis|xSafety regulations|zCanada. |
| 650 | 0|aCannabis|xSide effects|xReporting|zCanada. |
| 710 | 1 |aCanada. |bHealth Canada, |eissuing body. |
| 775 | 08|tPromotion de la conformité : |w(CaOODSP)9.954693 |
| 856 | 40|qPDF|s248 KB|uhttps://publications.gc.ca/collections/collection_2026/sc-hc/H134-45-2025-eng.pdf |
| 986 | |a250212 |